Biomedicines
(Jul 2023)
δ-Opioid Receptor as a Molecular Target for Increasing Cardiac Resistance to Reperfusion in Drug Development
Natalia V. Naryzhnaya,
Alexander V. Mukhomedzyanov,
Maria Sirotina,
Leonid N. Maslov,
Boris K. Kurbatov,
Alexander S. Gorbunov,
Mikhail Kilin,
Artur Kan,
Andrey V. Krylatov,
Yuri K. Podoksenov,
Sergey V. Logvinov
Affiliations
Natalia V. Naryzhnaya
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk 634021, Russia
Alexander V. Mukhomedzyanov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk 634021, Russia
Maria Sirotina
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk 634021, Russia
Leonid N. Maslov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk 634021, Russia
Boris K. Kurbatov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk 634021, Russia
Alexander S. Gorbunov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk 634021, Russia
Mikhail Kilin
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk 634021, Russia
Artur Kan
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk 634021, Russia
Andrey V. Krylatov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk 634021, Russia
Yuri K. Podoksenov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk 634021, Russia
Sergey V. Logvinov
Department of Histology, Embryology and Cytology, Siberian State Medical University, Tomsk 634050, Russia
DOI
https://doi.org/10.3390/biomedicines11071887
Journal volume & issue
Vol. 11,
no. 7
p.
1887
Abstract
Read online
An analysis of published data and the results of our own studies reveal that the activation of a peripheral δ2-opioid receptor (δ2-OR) increases the cardiac tolerance to reperfusion. It has been found that this δ2-OR is localized in cardiomyocytes. Endogenous opioids are not involved in the regulation of cardiac resistance to reperfusion. The infarct-limiting effect of the δ2-OR agonist deltorphin II depends on the activation of several protein kinases, including PKCδ, ERK1/2, PI3K, and PKG. Hypothetical end-effectors of the cardioprotective effect of deltorphin II are the sarcolemmal KATP channels and the MPT pore.
Keywords
WeChat QR code
Close